17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer

Joanna M. Day, Paul A. Foster, Helena J. Tutill, Michael F. C. Parsons, Simon P. Newman, Surinder K. Chander, Gillian M. Allan, Harshani R. Lawrence, Nigel Vicker, Barry V. L. Potter, Michael J. Reed, Atul Purohit

Research output: Contribution to journalArticle

95 Citations (Scopus)
Original languageEnglish
Pages (from-to)1931-1940
JournalInternational Journal of Cancer
Volume122
Issue number9
DOIs
Publication statusPublished - 2008

Cite this

Day, J. M., Foster, P. A., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., ... Purohit, A. (2008). 17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer. International Journal of Cancer, 122(9), 1931-1940. https://doi.org/10.1002/ijc.23350